Low dose aspirin reduces risk of dying from a range of cancersBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c7082 (Published 07 December 2010) Cite this as: BMJ 2010;341:c7082
- Zosia Kmietowicz
Taking 75 mg of aspirin every day for five years or more reduces the risk of dying from a range of common cancers, a review of randomised trials has found.
The benefit is unrelated to sex or smoking habit and increases with age, the review says (Lancet, doi:10.1016/S0140-6736(10)62110-1).
Tom Meade, of the London School of Hygiene and Tropical Medicine and one of the study’s authors, said that the findings are likely to “alter clinical and public health advice about low dose aspirin, because the balance between benefit and [gastrointestinal] bleeding has probably been altered towards using it.”
However, he cautioned that not everyone should automatically take aspirin. Health professionals and others would have to consider the practical implications, he said.
For the study the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial